Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of intravenous human beta natriuretic
peptide (BNP, Nesiritide) as compared to placebo to prevent adverse post acute myocardial
infarction left ventricular remodeling.